As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

By Dennis Thompson HealthDay ReporterTUESDAY, July 8, 2025 (HealthDay News) — A single mood disorder might have driven a ...

There are many obstacles ahead, including ongoing legal battles and strong opinions regarding the program’s structure and ...

So for now, the EU market is small when it comes to cannabis sales. This year sales are expected to reach $1.2 billion, ...

Medical marijuana was associated with “significant decreases in self-reported anxiety and depression” compared to before ...

Although 40 states have legalized medical marijuana, the federal government still lists it as a controlled substance.

In the first placebo-controlled study of vaporized cannabis for acute migraine, patients report greater relief from pain and ...

Officials say only around 2,000 of the country’s 18,000 marijuana dispensaries are expected to stay open after the new rules ...

Anxiety is now the number one health condition that Pennsylvania patients use medical marijuana to treat, according to a new ...

Australia's health-practitioner watchdog has released guidance for doctors prescribing medicinal cannabis, noting current ...

We reviewed 21 recent studies (published between 2021 and 2024) of cannabinoids being used for insomnia, subjective sleep impairment, obstructive sleep apnoea, rapid eye movement sleep behaviour ...

The latest announcement doesn’t tighten existing prescribing or marketing rules for medicinal cannabis. It just reminds ...